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Many eﬀorts have been directed at negating the inﬂuence of electromyographic (EMG) activity on the EEG, especially in elderly
dementedpatients.Wewonderedwhetherthese“artifacts”mightreﬂect cognitiveandbehaviouralaspectsofdementia.Inthispilot
study, 11 patients with probable Alzheimer’s disease (AD), 13 with amnestic mild cognitive impairment (MCI) and 13 controls
underwent EEG registration. As EMG measures, we used frontal and temporal 50–70Hz activity. We found that the EEGs of AD
patients displayed more theta activity, less alpha reactivity, and more frontal EMG than controls. Interestingly, increased EMG
activity indicated more cognitive impairment and more depressive complaints. EEG variables on the whole distinguished better
between groups than EMG variables, but an EMG variable was best for the distinction between MCI and controls. Our results
suggest that EMG activity in the EEG could be more than noise; it diﬀers systematically between groups and may reﬂect diﬀerent
cerebral functions than the EEG.
1.Introduction
There is at present no certain diagnostic test for Alzheimer’s
disease (AD). Much attention is devoted to identify speciﬁc
markers for AD and its presumed precursor stage, amnestic
mild cognitive impairment (MCI). One research technique
concerns the electroencephalogram (EEG), which has the
advantages of easy availability and low cost.
Research EEG eﬀorts focused on the search for parame-
ters that may help distinguish between healthy ageing, MCI,
and AD. AD is characterised by slowing of the EEG, which
ﬁnding can be quantiﬁed using spectral analysis [1]. Result-
ing variables such as ratios between fast and slow activity,
alpha and theta relative power, or the mean frequency have
shown varying degrees of eﬃcacy in this respect [2, 3].
Attemptshavebeenmade to increase the diﬀerencesbetween
groups by challenging the subjects, such as by a memory task
or more simply by comparing “eyes open” with “eyes closed”
conditions. For example, studies comparing AD with healthy
controls reported increased theta power and decreased alpha
suppression during eye opening and a memory task [1, 2,
4–6]. Compared to controls, EEG abnormalities in MCI
consisted ofdecreasedalphasuppression and increased alpha
powerduring a memory task [7, 8].Suchreports suggestthat
the EEG may have an ancillary role in the diagnostic workup
of AD and MCI, but it has not achieved a prominent place in2 International Journal of Alzheimer’s Disease
the diagnostic arsenal [9]. Many attempts have been made to
improvetheyieldoftheEEGforthispurpose.Itiscommonly
consideredoftheutmostimportancetoobtainahigh-quality
EEG, uncontaminated by artifacts such as blinks, eye move-
ments, and electromyographic (EMG) activity, which can be
extremely diﬃcult in dementia. Eye blinks and movements
mostoftencauselowfrequencypotentials,andmaytherefore
aﬀect the measurement of low frequency signals in the EEG,
that is, delta and theta waves [10, 11]. EMG activity is
usually due to activity of scalp, facial, and jaw muscles and
typically most strongly aﬀects frontal and temporal EEG
recordings [12]. It mostly aﬀects the high-frequency gamma
and beta bands. Over the years researchers devoted much
attention to dealing with these unwanted inﬂuences. One
approach is to reject contaminated epochs from analysis,
either manually or through automated methods [2, 10, 13].
Others attempted to negate eﬀects of artifacts using various
techniques [14–18], and yet others chose to simply disregard
aﬀected frequency bands, largely leaving theta and alpha
activity [8]. The rationale behind these intensive eﬀorts to
remove eye blinks, movements, and EMG from the EEG
is probably that the latter reﬂects “pure” cerebral activity,
whereas the “artifacts” donot. We donot doubtthat theEEG
reﬂects cerebral activity, but wondered whether the other
group of parameters can be dismissed out of hand. They
mayberegardedasbehaviouralcorrelates,andADultimately
aﬀects behaviour, in a chain of events involving amongst
others biochemistry, neuronal function, and cognition. It is
conceivable that the amount of muscle activity is related to
the degree of cognitive impairment or to neuropsychiatric
symptoms such as agitation, irritability, and depression. If
so, then these behavioural correlates may reﬂect the presence
of AD. How well the EEG does so has been investigated, but
how well behavioural “contaminations” do so has, to our
knowledge, not been tested.
In this pilot study, we explored the discriminative value
ofquantitative EEGand EMG in distinguishing between AD,
MCI and healthy aging. Furthermore, we examined whether
EMG activity was related to neuropsychiatric and cognitive
measures.
2.Materialsand Methods
2.1. Participants. Thirteen age-matched controls, 13 patients
diagnosed with MCI [19], and 11 diagnosed with probable
AD [20] participated in the study. Patients had been referred
to the outpatient memory clinic of the Leiden Univer-
sity Medical Centre. Control subjects without cognitive
complaints were recruited through an advertisement in
a local newspaper. All patients and controls underwent
generalmedical, neurological,neuropsychological,andbrain
MRI investigations as part of the standardized dementia
screening. Furthermore, all patient histories were reviewed
and diagnoses reached in multidisciplinary consensus meet-
ings. Within three months from the standardized dementia
screening, patientsand controls participated in an additional
EEG examination. Eligible subjects had to be free of psy-
chotropic medication, aged 60 years or above, and without
previous history of psychiatric and neurological disorders
or substance abuse. Moreover, they had no abnormalities
on MRI other than white matter hyper intensities or an
incidentalsmall lacunar lesion(≤5mmdiameter).Thestudy
was approved by the local Medical Ethical Committee.
Written informed consent was obtained from all subjects, or
from close relatives or caregivers in case of dementia.
2.2. Neuropsychiatric and Cognitive Assessment. The Geri-
atric Depression Scale (GDS), a patient-based interview,
was used to determine the presence and severity of depres-
sive feelings [21]. We used the Neuropsychiatric Inventory
(NPI-Q) [22], an informant-based interview, to determine
the presence and severity of neuropsychiatric problems
(i.e.,delusions, hallucinations, agitation,depression, anxiety,
euphoria, apathy, disinhibition, irritability, aberrant motor
activity, night-time behavioural disturbances, and eating
disturbances). Per item a score from “0” to “3” could be
obtained, with “0” indicating the absence of a neuropsy-
chiatric problem and “1”, “2”, and “3” indicating a mild,
moderate,and severeneuropsychiatric problem,respectively.
NPI items were clustered based on previous research using
principal component analysis [23]. Three factors were used
(1) a “mood/apathy” factor including depression, apathy,
night-time behavioural disturbances, and eating distur-
bances, (2) a “hyperactivity factor” including agitation,
euphoria, irritability, disinhibition, and aberrant motor
activity, and (3) a “psychosis” factor includinghallucinations
and delusions. Anxiety was considered a separate factor, but
it was excluded from further analysis because of limited
variability in scores. The Cambridge cognitive examination
(CAMCOG) [24] was used to provide a measure of general
cognitive functioning.
2.3. EEG Recording and Analysis. EEGs were recorded using
a Nihon Kohden 2110 apparatus with 21 Ag/AgCl electrodes
p l a c e da c c o r d i n gt ot h e1 0 / 2 0s y s t e m .E C G ,r e s p i r a t i o n ,a n d
horizontal eye movement leads were recorded to facilitate
recognitionofartifacts. TheEEGwas band-pass ﬁlteredfrom
0.16–70Hz for display and analysis but recorded unﬁltered.
The sample frequency was 200Hz and the AD precision
12 bits. The average reference montage was used, with the
exclusion of electrodes Fp1, Fp2, A1, and A2. All EEGs were
recorded in the afternoon. During recording, subjects sat
slightly reclined in a comfortable chair, approximately 1.5m
in front of a computer screen. The light in the room was
dimmed.
The EEG was registered during a 10-minute eyes-closed
period, a 3-minute eyes-open period, and during memory
activation. The memory activation task concerned picture
memory. Subjects were consecutively shown 10 pictures of
common objects on a computer screen. Each picture was
presented for two seconds and subjects were asked to name
the shown objects aloud. After presentation of the pictures,
subjects had to close their eyes and memorise the pictures
for 15 seconds. This period was later used for data analysis.
Subjects were then asked to open their eyes and name as
many picturestheycouldremember.The taskwasperformed
three times using the same 10 pictures. The number of
remembered pictures was noted.International Journal of Alzheimer’s Disease 3
2.4. EEG Parameters. To study EEG parameters, we selected
speciﬁc periods of the EEG using visual analysis. Samples
had to be free of eye movements, blinks, and muscle activity.
Sample selection was performed by the ﬁrst author and
corroborated by an experienced clinical neurophysiologist.
Both were blind to clinical diagnosis. Samples had to be 4–8
seconds in lengthand were selected during conventionaleyes
closed and eyes open, and memory activation. Frequency
analysis was performed using a fast Fourier transformation.
We calculated absolute power in theta (4–8Hz) and alpha
(8–13Hz) frequency bands.
Three parameters were then calculated: theta relative
power during eyes closed, and alpha reactivity during both
eye opening and memory activation. Alpha reactivity is
deﬁned as the percentile decrease in absolute alpha power as
compared tothe eyesclosedcondition.EEG parameters were
averaged over all electrodes and over the three selected EEG
samples available for each of the eyes closed, eyes open, and
memory activation periods. We chose these EEG parameters
as they were found sensitive to AD and MCI in previous
research [1, 2, 4–6, 8]. All signal processing was performed
using MATLAB (The MathWorks, Natick, USA).
2.5. EMG Parameters. To measure the amount of EMG
activity, we did not select speciﬁc periods but used the
entire period corresponding to the eyes closed, eyes open,
and each of the three memory activation periods. The only
selection involved was that periods in which the tasks were
compromised by matters such as electrode correction were
omitted. Frequency analysis was performed using a fast
Fourier transformation. As a measure of EMG activity,
absolute power was calculated in the high frequency band
(50–70Hz) and averagedovertemporal (T3, T4, T5, and T6)
and frontal electrodes (F3, F4, F7, and F8). These sites are
sensitive to EMG activity from scalp, facial, and jaw muscles.
The 50Hz threshold was chosen to exclude any possible
confusion with brain activity, that is, beta or gamma activity,
that might be present at lower frequencies. In doing so, we
aimed to ensure that the measured activity was the result of
muscle activity only.
For analysis, we used temporal and frontal EMG during
eyes closed,eyesopen, and memory activation. EMG param-
eters were averaged over the three samples available for the
memory activation periods.
2.6. Statistical Analysis. SPSS for Windows (release 14.0.1)
was used for data analysis. Group diﬀerences in cognitive
and neuropsychiatric outcomes, EEG, and EMG activity
were assessed using ANOVA with post hoc Bonferroni tests.
When data were not normally distributed we used two-
sample Kolmogorov-Smirnov tests to assess group diﬀer-
ences. Subsequently, we performed a two-tailed parametric
or nonparametric correlation analysis to investigate relations
between EEG and EMG activity on the one hand and
cognitive and neuropsychiatric parameters on the other. We
did not investigate correlations in speciﬁc diagnostic groups
because of the limited number of subjects per group. The
level of signiﬁcance was set at P ≤ .05.
Table 1: Clinical characteristics.
Controls MCI AD
male/ femalea 3/10 6/7 6/5
age (years) 73 (5) 73 (5) 75 (8)
education (years) 10 (3) 11 (4) 10 (4)
CAMCOG (max 106) 96 (4) 85 (6)∗∗ 68 (10)∗∗##
Picture memory score
(max 30) 25 (2) 15 (3)∗∗ 10 (4)∗∗##
GDS (max 15)b 0.8 (1.2) 2.1 (1.7) 1.8 (1.6)
NPI “mood/apathy”
(max 12) — 2.0 (1.2) 2.4 (2.7)
NPI “hyperactivity”
(max 15) — 2.0 (1.9) 2.8 (1.9)
NPI “psychosis”
(max 6) — 0 (0) 0.8 (1.3)
Values in the table are means with S.D. in parentheses. ANOVA was used to
assess group diﬀerences, except for: aχ2-test was used and bNonparametric
two sample Kolmogorov-Smirnov tests were used. In view of the small
number of MCI and AD patients forwhom an NPI was available,we did not
assess group diﬀerences. ∗∗diﬀers from controls (P<. 01); ##diﬀers from
MCI patients (P<. 01). CAMCOG: Cambridge Cognitive Examination;
GDS: Geriatric Depression Scale (N: 13 controls, 12 MCI and 9 AD); NPI:
Neuropsychiatric Inventory (N: 5 MCI and 5 AD).
The aim of the study was to compare not only whether
EEG and EMG parameters diﬀered between groups but
also whether they did so to diﬀerent degrees. We assumed
they could not be compared directly, because of wholly
diﬀerent distribution patterns including various nonnormal
distributions. We also wished to avoid subjective choices
regarding abnormality thresholds. To avoid such problems,
we chose to plot receiver operating curves. The area under
the curve serves as a quantitative indicator of how well
a speciﬁc parameter distinguishes between groups, irrespec-
tive of the nature of the parameter in question. This value
usually ranges between 0.5 (meaning the parameter does not
distinguish between the groups at all) to 1.0 (the parameter
separates the two groups perfectly). We will assume that
values below 0.75 have little relevance.
3.Results
3.1. Clinical Characteristics. Clinical characteristics are
shown in Table 1.S e x ,a g e ,y e a r so fe d u c a t i o n ,a n dG D S
scores did not diﬀer between groups. Group diﬀerences were
found in CAMCOG scores (F(2,34) = 50.0; P<. 001).
Post hoc tests showed that AD patients had signiﬁcantly
lower CAMCOG scores than controls and MCI patients
(P<. 001). Furthermore, MCI patients had lower CAMCOG
scores (P<. 001) than controls. There were also diﬀerences
in the number of pictures correctly remembered in the
memory task used during EEG registration (F(2,34) = 72.6;
P<. 001). Post hoc tests showed that AD and MCI patients
remembered less pictures than controls (P<. 001). Fur-
thermore, AD patients had a lower score than MCI patients
(P<. 01).4 International Journal of Alzheimer’s Disease
3.2. EEG and EMG. Table 2 shows EEG and EMG data.
Group diﬀerences in theta relative power were found during
eyes closed (F(2,34) = 10.6; P<. 001). Post hoc tests
indicated that AD patients showed signiﬁcantly higher theta
relative power as compared with controls and MCI patients
(both P<. 001). Alpha reactivity upon eyes opening and
memory activation also diﬀered between groups (F(2,34) =
5.3; P<. 01 and (F(2,34) = 6.1; P<. 01) in that alpha
reactivity was decreased in AD patients as compared with
controls.
Group diﬀerences in frontal EMG were found during
both eyes closed and eyes open (F(2,34) = 3.8; P<. 05 and
Kolmogorov-Smirnov Z = 1.4; P<. 05). AD patients showed
more frontal EMG activity than controls.
3.3. Correlation Analyses. Correlations are shown in Table 3.
Theta relative power, alpha reactivity during eyes open, and
alpha reactivity during memory activation were related to
CAMCOG scores; lower theta relative power and higher
alpha reactivity indicated higher CAMCOG scores, and thus
better cognitive performance. Furthermore, frontal EMG
during eyes open was related to CAMCOG scores in that
increased EMG activity indicated lower CAMCOG scores.
Correlations were found between, on the one hand,
frontal EMG during eyes closed, temporal EMG during eyes
closed, and temporal EMG during eyes open and, on the
other hand, GDS scores (see Table 3). In all cases, increased
EMG activity indicated more complaints of depression. No
correlations were found between EEG and EMG parameters
and neuropsychiatric complaints on the NPI.
3.4. Receiver Operating Curves. ROC data are shown in
Table 4.O ft h e9E E GR O C s ,4r e a c h e dl e v e l sa b o v e
0.75. Three of these concerned the comparison between
AD patients and controls, and the fourth the AD-MCI
comparison.
Of the 18 EMG ROCs, 3 reached levels above 0.75. Two
concerned the AD-control comparison, and one the MCI-
control comparison.
4.Discussion
EMG activity is usually regarded a source of problems
in EEGs used for patient care and research purposes in
dementia, because the EMG impairs the registration of the
EEG.This isparticularly relevantforactivityatthehigh(beta
and gamma) and low (delta)ends of the spectrum. The most
importantnewﬁndingofthispilotstudyisthatEMGactivity
could be not only a hindrance but also reﬂects some aspects
of AD and MCI. We base this conclusion on two lines of
evidence.
Firstly, the amount of frontal EMG activity was higher in
theADgroupthanincontrols,bothduringtheeyesopenand
eyes closed conditions. As such, its presence is linked to the
presence of AD, presumably through an association between
facial muscle activity and the expression of emotions such as
depression. The ROC analysis corroborates this ﬁnding. We
used this type of analysis to allow us to compare variables of
Table 2: EEG and EMG data.
Controls MCI AD
Eyes closed
EEG theta relative power (%) 28 (8) 29 (14) 53
(21)∗∗##
Frontal EMG (μV2) 2 (1) 6 (5) 7 (7)∗
Temporal EMG (μV2) 4 (4) 9 (8) 8 (10)
Eyes open
EEG alpha reactivity (%) 67 (20) 59 (18) 37 (32)∗∗
Frontal EMG (μV2)a 6 (4) 16 (25) 24 (34)∗
Temporal EMG (μV2)a 10 (8) 15 (25) 18 (30)
Memory activation
EEG alpha reactivity (%) 40 (33) 10 (32) −7 (35)∗∗
Frontal EMG (μV2)a 3 (2) 13 (15) 21 (41)
Temporal EMG (μV2)a 6 (5) 19 (26) 14 (16)
Values in the table are means with S.D. in parentheses. ANOVA was
used to assess group diﬀerences, except for: aNonparametric two sample
Kolmogorov-Smirnov tests were used. ∗diﬀers from controls (P ≤ .05);
∗∗diﬀers from controls (P ≤ .01); ##diﬀers from MCI patients (P<. 01).
ad i ﬀerent nature, that is, EEG and EMG. This comparison
shows that EEG variables on the whole distinguish better
between the groups than EMG variables and also that EMG
variables are not worthless in this respect. In fact, for the
distinction between MCI and controls, it was an EMG
variable that best distinguished between groups.
Secondly, EMG activity cannot be considered as an aspe-
ciﬁc ﬁnding: we found signiﬁcant relations between EMG
activityandpatient-basedreportsofdepression.It,therefore,
seems likely that the EMG reﬂects disease-related neuropsy-
chiatric changes. The relation between facial EMG activity
and depression has been studied previously: for instance,
when depressed subjects generated sad thoughts or simply
thoughtabouta typicaldayintheircurrentlives, the amount
of facial EMG activity increased [25]. It canbe imagined that
a degree of depression in patients with memory complaints
is expressed as an increased facial EMG. Asonemight expect,
diﬀerent emotions lead to diﬀerent patterns of EMG activity
in various muscles [26]. In the context of an EEG, it seems
likely that activity of the frontalis, corrugator supercilii, and
zygomatic major muscles are picked up preferentially. These
muscles are indeed involved in aﬀective reactions, such as
distress and pleasure. Note that we made no eﬀort to record
these muscles with any degree of precision, so we refrain
from drawing detailed conclusions in this regard.
It may well be argued that even if there is more EMG
activity in AD than in controls, this has little bearing
on the understanding of the pathophysiology of AD. In
part we agree; the EMG reﬂects muscle activation and is
thus a behavioural correlate, while the EEG is a direct
reﬂection of cerebral function. Decreased EEG activity has
been linked with functional disconnections among cortical
areas, resulting among others from neuronal death and/or
deﬁciency of neurotransmitters [1]. This is no doubt true,
but it should be kept in mind that it is doubtful which
cerebral functions are expressed in the various rhythms ofInternational Journal of Alzheimer’s Disease 5
Table 3: Correlations between EEG and EMG activity on the one hand and cognitive and neuropsychiatric scores on the other hand.
CAMCOG GDSa NPI mood/apathy NPI hyperactivity NPI psychosisa
Eyes closed
EEG theta relative
power
−0.54∗∗ 0.32 −0.45 −0.08 −0.14
Frontal EMG −0.25 0.52∗∗ 0.43 0.30 −0.11
Temporal EMG −0.12 0.39∗ −0.01 −0.32 −0.24
Eyes open
EEG alpha reactivity 0.53∗∗ −0.04 0.43 0.17 −0.02
Frontal EMGa −0.43∗∗ 0.33 0.13 0.20 −0.01
Temporal EMGa −0.05 0.35∗ 0.42 0.07 −0.24
Memory activation
EEG alpha reactivity 0.43∗∗ −0.28 0.11 0.23 −0.37
Frontal EMGa −0.24 0.28 −0.21 0.07 −0.07
Temporal EMGa −0.30 0.28 −0.06 −0.11 −0.36
ValuesinthetablearePearson’scorrelationcoeﬃcients.In aSpearman’scorrelationcoeﬃcientsaredisplayed,asvalueswerenotnormallydistributed. ∗P ≤ .05
and ∗∗P ≤ .01. Signiﬁcant correlations are printed in bold. CAMCOG: Cambridge Cognitive Examination; GDS: GeriatricDepression Scale (N: 13 controls,
12 MCI and 9 AD); NPI: NeuropsychiatricInventory (N: 5 MCI and 5 AD).
Table 4: Classiﬁcation accuracy of EEG and EMG parameters by
receiver operating curves (ROC).
ROC area under the curve
AD versus
controls
MCI versus
controls
AD versus
MCI
Eyes closed
EEG theta relative power (%) 0.92 0.50 0.85
Frontal EMG (μV2) 0.78 0.83 0.52
Temporal EMG (μV2) 0.64 0.73 0.41
Eyes open
EEG alpha reactivity (%) 0.82 0.65 0.72
Frontal EMG (μV2) 0.86 0.61 0.71
Temporal EMG (μV2) 0.49 0.51 0.50
Memory activation
EEG alpha reactivity (%) 0.84 0.74 0.67
Frontal EMG (μV2) 0.74 0.73 0.47
Temporal EMG (μV2) 0.69 0.70 0.49
Areas under the curve of over 0.75 are printed in bold.
the EEG. For example, slowing of the EEG is not speciﬁc
to the type of dementia, in spite of completely diﬀerent
pathophysiological substrates. In fact, EEG slowing is not
even speciﬁc to dementia, as this also occurs in a large
variety of other conditions ranging from mechanical trauma
to intoxications. One may wonder whether EEG slowing is
really so much closer to the pathology of AD than EMG
activity.
Inthepresentstudy,theEEGgenerallyresultedinabetter
discrimination between groups than the EMG, except for
the MCI-control distinction, in which the EMG performed
better. We do not suggest that henceforth the EMG should
be used for discriminating MCI patients and controls, as we
made no attempt to optimise recordings for this purpose.
For similar reasons, we did not calculate measures such
as sensitivity and speciﬁcity even though many attempts
have been made to optimise the EEG for this purpose.
Regarding optimisation, the bestparameter might bethe one
that accurately reﬂects the presence of a pathogenic cause.
An example is measuring the number of CAG repeats in
Huntington’s disease, reﬂecting the pathogenetic cause. The
test however does not reﬂect the degree of aﬄiction at all.
EEG parametersdonotreﬂect thepathogeneticcausebutthe
degree of aﬄi c t i o n .A st h i sv a r i e sf r o mn o r m a lt os e v e r e l y
abnormal, there must be an overlap in function in early
phases. This may be seen as a failure of the test to pick up
any diﬀerences, but it seems more likely that the overlap
truthfully represents an overlap in function. The best we can
do may be to push against the detection boundary, and in
this respect, it may pay to keep an open mind regarding the
nature of the parameter to be measured.
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